Correlation Between Dupont De and Chordate Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Chordate Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Chordate Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Chordate Medical Holding, you can compare the effects of market volatilities on Dupont De and Chordate Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Chordate Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Chordate Medical.

Diversification Opportunities for Dupont De and Chordate Medical

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dupont and Chordate is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Chordate Medical Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chordate Medical Holding and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Chordate Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chordate Medical Holding has no effect on the direction of Dupont De i.e., Dupont De and Chordate Medical go up and down completely randomly.

Pair Corralation between Dupont De and Chordate Medical

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.22 times more return on investment than Chordate Medical. However, Dupont De Nemours is 4.54 times less risky than Chordate Medical. It trades about 0.05 of its potential returns per unit of risk. Chordate Medical Holding is currently generating about -0.06 per unit of risk. If you would invest  6,773  in Dupont De Nemours on September 4, 2024 and sell it today you would earn a total of  1,599  from holding Dupont De Nemours or generate 23.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.94%
ValuesDaily Returns

Dupont De Nemours  vs.  Chordate Medical Holding

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Chordate Medical Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chordate Medical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dupont De and Chordate Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Chordate Medical

The main advantage of trading using opposite Dupont De and Chordate Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Chordate Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chordate Medical will offset losses from the drop in Chordate Medical's long position.
The idea behind Dupont De Nemours and Chordate Medical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators